It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2016
  5. New 1 mg Tablet Dosage of Antipsychotic ABILIFY Available in Japan

November 18, 2016

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

New 1 mg Tablet Dosage of Antipsychotic ABILIFY Available in Japan

Otsuka Pharmaceutical Co., Ltd. will be released in Japan the additional 1 mg tablet dosage of the antipsychotic ABILIFY (generic name: aripiprazole) on November 29 2016. In September, ABILIFY obtained the indication of irritability associated with pediatric autistic spectrum. The 1 mg dosage is the starting dosage.

ABILIFY received approval from the U.S. FDA in 2009 for use in pediatric patients with irritability associated with autism disorders.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases